Philip Cunningham
Dados Biográficos
| ID | 7450684 |
|---|---|
| NOME | Philip Cunningham |
| PRENOMES | Philip |
| SOBRENOME | Cunningham |
| ASSINATURA | CUNNINGHAM P |
| AFILIAÇÕES | St Vincent's Hospital Sydney |
| ORCID | 0000-0003-2613-6910 |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2017 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey
The temporal decline in HCV Ab prevalence appears related to reduced sensitivity of DBS HCV Ab detection with viral clearance following treatment. Since 2016, HCV treatment uptake has increased markedly including among people who inject drugs. In this context, continuing to monitor HCV Ab prevalence by DBS testing is problematic, with a shift to surveillance of active infection the most relevant to guide policy and practice in this setting
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
Sem obras proeminentes nesta página.
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia
Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey
The temporal decline in HCV Ab prevalence appears related to reduced sensitivity of DBS HCV Ab detection with viral clearance following treatment. Since 2016, HCV treatment uptake has increased markedly including among people who inject drugs. In this context, continuing to monitor HCV Ab prevalence by DBS testing is problematic, with a shift to surveillance of active infection the most relevant to guide policy and practice in this setting
Hepatitis C (3 obras) · Hepatitis C virus research (3 obras) · HIV, Drug Use, Sexual Risk (3 obras) · Medicine (3 obras) · Virology (3 obras) · Environmental health (2 obras) · Hepatitis C virus (2 obras) · HIV/AIDS Research and Interventions (2 obras) · Internal Medicine (2 obras) · Psychiatry (2 obras)